TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
RSA Biomedical AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,629
|
4,863
|
5,716 |
Financial expenses |
1
|
2
|
3 |
Earnings before taxes |
2,761
|
1,972
|
2,485 |
EBITDA |
2,230
|
2,043
|
2,563 |
Total assets |
5,036
|
4,019
|
4,157 |
Current assets |
4,767
|
3,676
|
3,739 |
Current liabilities |
1,353
|
1,536
|
1,786 |
Equity capital |
3,327
|
2,226
|
2,224 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
66.1%
|
55.4%
|
53.5% |
Turnover per employee |
2,314
|
2,432
|
2,858 |
Profit as a percentage of turnover |
59.6%
|
40.6%
|
43.5% |
Return on assets (ROA) |
54.8%
|
49.1%
|
59.9% |
Current ratio |
352.3%
|
239.3%
|
209.4% |
Return on equity (ROE) |
83.0%
|
88.6%
|
111.7% |
Change turnover |
-234
|
-853
|
-70 |
Change turnover % |
-5%
|
-15%
|
-1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.